Taken together, our study showed that C1GALT1 high expression is an independent prognostic factor and predicts better survival outcomes for NB patients, complementary to age of patients, differentiation status of tumor, MYCN status, and clinical stages. The gene discussed is MYCN; the disease is neuroblastoma.